510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K973784Substantially Equivalent

Triage Panel for Drugs of Abuse, Plus Tricyclic Antidepressants and Other Triage Drug Tests

Biosite Incorporated, San Diego CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K973784 is the FDA 510(k) clearance record for TRIAGE PANEL FOR DRUGS OF ABUSE, PLUS TRICYCLIC ANTIDEPRESSANTS AND OTHER TRIAGE DRUG TESTS, a class II device, cleared for Biosite Incorporated on under FDA product code DKZ (Enzyme Immunoassay, Amphetamine). FDA records list 46 510(k) clearances for Biosite Incorporated, from to . As of , FDA records show 4 recalls naming K973784.

Clearance record

Decision date
Received
(61 days to decision)
Product code
DKZ Enzyme Immunoassay, Amphetamine
Regulation
21 CFR 862.3100
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Biosite Incorporated 11030 Roselle St., San Diego CA
510(k) summary
Statement
Third party review
No

Clearances, product code DKZ

Trailing 12 months

FDA records hold no clearances under product code DKZ in the trailing twelve months.

FDA records show no clearances under product code DKZ in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code DKZ, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260